Evidence that cisplatin-induced auditory damage is attenuated by downregulation of pro-inflammatory cytokines via Nrf2/HO-1
about
Cisplatin ototoxicity and protection: clinical and experimental studiesIL-10/HMOX1 signaling modulates cochlear inflammation via negative regulation of MCP-1/CCL2 expression in cochlear fibrocytes.Heat shock protein-mediated protection against Cisplatin-induced hair cell death.Loss of STAT1 protects hair cells from ototoxicity through modulation of STAT3, c-Jun, Akt, and autophagy factors.Cisplatin inhibits hippocampal cell proliferation and alters the expression of apoptotic genes.T-type calcium channel blockers as neuroprotective agents.Protection by low-dose kanamycin against noise-induced hearing loss in mice: dependence on dosing regimen and genetic backgroundTAK1 expression in the cochlea: a specific marker for adult supporting cells.NOX3 NADPH oxidase couples transient receptor potential vanilloid 1 to signal transducer and activator of transcription 1-mediated inflammation and hearing lossShort interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammationExpression of fractalkine receptor CX3CR1 on cochlear macrophages influences survival of hair cells following ototoxic injury.Drug screening for hearing loss: using the zebrafish lateral line to screen for drugs that prevent and cause hearing loss.Role of the copper transporter, CTR1, in platinum-induced ototoxicity.The role of the catecholic and the electrophilic moieties of caffeic acid in Nrf2/Keap1 pathway activation in ovarian carcinoma cell lines.Cisplatin ototoxicity involves cytokines and STAT6 signaling network.Naringenin Inhibits Superoxide Anion-Induced Inflammatory Pain: Role of Oxidative Stress, Cytokines, Nrf-2 and the NO-cGMP-PKG-KATP Channel Signaling PathwayHistone deacetylase inhibition activates Nrf2 and protects against osteoarthritisAdenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea.Capsaicin ameliorates cisplatin-induced renal injury through induction of heme oxygenase-1.NLRX1 accelerates cisplatin-induced ototoxity in HEI-OC1 cells via promoting generation of ROS and activation of JNK signaling pathway.Reactive oxygen species in apoptosis induced by cisplatin: review of physiopathological mechanisms in animal models.Novel synthetic protective compound, KR-22335, against cisplatin-induced auditory cell death.Auditory cells produce nitric oxide in response to bacterial lipopolysaccharide.Promoter region variation in NFE2L2 influences susceptibility to ototoxicity in patients exposed to high cumulative doses of cisplatin.Cisplatin-Induced Ototoxicity: Effects, Mechanisms and Protection Strategies.Interleukin-10 Attenuates Hypochlorous Acid-Mediated Cytotoxicity to HEI-OC1 Cochlear Cells.Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection.Progress in the Development of Preventative Drugs for Cisplatin-Induced Hearing Loss.Protection of Nrf2 against arsenite-induced oxidative damage is regulated by the cyclic guanosine monophosphate-protein kinase G signaling pathway.Heme oxygenase-1 exerts pro-apoptotic effects on hepatic stellate cells in vitro through regulation of nuclear factor-κB.
P2860
Q24628775-13FFD099-660C-43AE-B3DD-B5A365C99207Q30385810-1FDEFA9B-4CDE-47DB-981F-80929DF88101Q30392315-E577FB8B-5847-4F38-858D-925F3D266EF6Q30392973-0785A5EB-373E-44E4-AA05-8F239628A5B6Q30413236-B8D1AC3E-5355-4C01-BDE1-DE80EE819707Q30415535-75252DC9-598C-419C-A15C-E0EB3012108EQ30462907-646B5EEF-555E-426C-8F8A-199B3845266EQ30465209-204804DB-4E74-4DD3-9C87-52CF64A50E29Q30469563-E862D3AC-370C-4626-AFED-1332E92F0E8BQ30473608-2DAD87AA-2481-4C77-BF64-46AAD3D41ECDQ30475313-1FB325B5-F733-4397-A39C-A849C599D672Q30476012-D156C203-812A-4EBE-9328-7F20D7E03B8EQ30477867-51710D76-3D51-4266-9E09-D6BF5432FAC4Q35024476-5A181A31-3A17-4869-B153-7E50F52936DFQ35469656-96BE7D3F-6478-468D-8A8F-5A7B30643953Q35979615-F33FE2BE-C390-4FEF-A401-C5D582C61986Q36095497-B3F68511-063C-4699-8618-CA200FE2F6FDQ36768399-62A2785C-2768-42E9-8D42-E9EA39D01B99Q37671245-1B080D4E-D225-4C2E-A23A-07DC758E5E78Q37695375-DDB7145D-67C1-4CA0-9182-EFE845941AB4Q38010040-8FFAD349-01FC-410B-8FEB-8827DF14A7B0Q39214696-F295A7AD-64D8-4505-A568-2DFC4F07C5B4Q39325344-90AC0799-8A2C-4CBA-8004-589F10C9099CQ40600080-DE257735-BFB5-47E1-B09A-EFB343D1C6F3Q42361422-60CB378A-D67B-4F5D-A8CF-A3AAA782079AQ46124483-2B8FB80E-EE53-4D32-AD68-1562E39CCFA7Q46256727-BA325B0D-1BA7-4383-97CE-0E4268529207Q47716828-59A0B9BD-8001-4C17-A4C3-41C2D4A93C18Q48959587-12F76CD8-DAE4-4432-8F60-55FDF6C96947Q55034998-75376533-8545-4841-91FE-6F49F795C23B
P2860
Evidence that cisplatin-induced auditory damage is attenuated by downregulation of pro-inflammatory cytokines via Nrf2/HO-1
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Evidence that cisplatin-induce ...... matory cytokines via Nrf2/HO-1
@en
type
label
Evidence that cisplatin-induce ...... matory cytokines via Nrf2/HO-1
@en
prefLabel
Evidence that cisplatin-induce ...... matory cytokines via Nrf2/HO-1
@en
P2093
P2860
P1433
P1476
Evidence that cisplatin-induce ...... matory cytokines via Nrf2/HO-1
@en
P2093
Eunsook Kim
Haa-Yung Lee
HongSeob So
Hun-Taeg Chung
Hye-Jung Kim
Hyun-Ock Pae
HyungJin Kim
Kang-Beom Kwon
Kang-Min Lee
Raekil Park
P2860
P2888
P304
P356
10.1007/S10162-008-0126-Y
P577
2008-06-27T00:00:00Z